Sweden's Alligator Bioscience AB said Janssen Biotech Inc. has terminated its 2015 licensure of the Swedish company's CD40-directed antibody, ADC-1013, following a strategic portfolio decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results